Sarcoma Research
Why funding matters
Sarcoma represents just 1% of all adult cancers. As a result, progress in sarcoma research and treatment development has been slower than in more common cancer types — but sarcoma sufferers still require treatment and care. This means the need for increased funding in sarcoma research has never been higher.
Research at The Royal Marsden includes participating in:
- World-leading sarcoma treatment and research.
- New approaches in sarcoma: classification, treatment and quality of life for sarcoma patients.
- Latest studies in sarcoma: genetic risk — International Sarcoma Kindred Study (ISKS).